News

Stay up to date on the latest news and tweets of the Pereira Lab!

Filipe Pereira awarded the Emerging Alumni Leader Award 2025 from Imperial College London

Filipe Pereira completed his PhD in Biomedical Sciences in 2009 at Imperial College London, UK. He is now being awarded the prestigious Emerging Alumni Award for Imperial’s graduates with breakthroughs that placed them as “rising stars, innovators, game-changers and future leaders”. This award celebrates inspiring mentors and great leaders in their respective fields, who are unafraid of taking risks and collaborating to produce significant social impact and tackle global problems.

Luís Oliveira Wins the Researcher’s Grand Prix 2024

Luís Oliveira won the Forskar Grand Prix, securing the fifth win in a row for Lund University. The competition involves researchers from all over Sweden and the prize is awarded to the candidate who best presents their research in an engaging and entertaining way. At the final in Stockholm, Luís impressed an audience of 550 students, several of whom felt truly inspired and are considering a career in science.

Filipe Pereira and team are awarded with the Pfizer Award for Basic Research

The research study “Restoring tumor immunogenicity with dendritic cell reprogramming” was awarded with the Pfizer Award for Basic Research. The findings depicted in the Science Immunology publication in 2023 reported a strategy to overcome tumor evasion mechanisms by the cell fate reprogramming of tumor cells into dendritic cells.

The Knut and Alice Wallenberg Foundation (KAW) awards the Pereira Lab a project grant to support “Neoantigen discovery with cellular reprogramming”

Our team was awarded with a KAW project grant that aims to use dendritic cell reprogramming for neoantigen identification, forwarding an alternative to boost the efficiency of current immunotherapies based on vaccines and neoantigen-specific T cell therapies.

In Vivo Dendritic Cell Reprogramming for Cancer Immunotherapy

The Pereira Lab reports for the first time the in vivo reprogramming of cancer cells into type 1 conventional dendritic cells (cDC1s). The study was published in Science and showcases a new cancer immunotherapy modality.

Beatriz Vaz and Mariana Gonçalves awarded with PhD Studentships from The Foundation for Science and Technology (FCT)

The researchers Beatriz Vaz and Mariana Gonçalves from Pereira Lab were awarded with PhD studentships from the Foundation for Science and Technology (FCT). Both PhD projects aim to surpass the limitations of current cancer immunotherapies, addressing different strategies to reprogram cancer cells into antigen-presenting type 1 conventional dendritic cells (cDC1s), which are pivotal for anti-tumor immunity.

The European Research Council (ERC) awards the project DART with an ERC Proof of Concept

The Pereira Lab secures its third ERC grant with the project DART – “Driving Tumor Antigen Presentation by RNA-mediated Transdifferentiation.” The awarded project aims to develop an effective approach to perform RNA-based reprogramming of tumor cells into dendritic cells. DART is built on clinical and industry collaborations: Cristiana Pires and Fábio Rosa from Asgard Therapeutics, Anders Wittrup from Lund University, and Inge Marie Svane from Herlev Hospital in Denmark.

Camila Vazquez Echegaray Awarded a Cancerfonden Postdoctoral Fellowship

Pereira Lab researcher Camila Vazquez Echegaray was awarded a Postdoctoral Fellowship by Cancerfonden, the Swedish Cancer Society.

Pereira Lab Hosts the Resync Kick-Off Meeting

The RESYNC project, a European Innovation Council-funded consortium, launched its Kick-off meeting on March 1st in Lund, Sweden.

The Pereira Lab was Awarded a Pathfinder Open Grant by the European Innovation Council (EIC)

The Pereira Lab was awarded 33 million SEK by the European Innovation Council, under the EIC Pathfinder call.

Filipe Pereira Awarded the Lund Fernström Prize

Filipe Pereira was awarded this year’s Fernström Prize for his work on reprogramming hematopoietic cells and immunotherapy development.

Ilia Kurochkin Awarded a CRI Fellowship

Pereira Lab researcher Ilia Kurochkin was awarded an Immuno-Informatics Postdoctoral Fellowship by the Cancer Research Institute (CRI).

The Pereira Lab was Awarded an ERC Proof of Concept Grant

The Pereira Lab was today announced as the receiver of a Proof of Concept Grant from the European Research Council (ERC).

The Pereira Lab Was Awarded the NovoNordisk Distinguished Innovator Grant

The Pereira Lab has been awarded with a grant of 6.000.000 DKK from the NovoNordisk foundation.

Diogo Cabral Awarded a Maria de Sousa PhD Studentship From The Foundation for Science and Technology

Pereira Lab researcher Diogo Cabral was awarded a Maria de Sousa PhD Studentship by the Portuguese Foundation for Science and Technology (FCT).

3 Members of the Pereira Lab Awarded Grants from the Royal Physiographic Society of Lund

Pereira Lab PhD student Rita Alves and postdoctoral fellows Ilia Kurochkin and Camila Vasquez were each awarded a grant from the Royal Physiographic Society of Lund.

Filipe Pereira Appointed Professor at Lund University

Pereira Lab group leader Filipe Pereira has been appointed Professor of Molecular Medicine, Regeneration, Transplantation and Repair in the Hematopoietic System at Lund University.

Camila Vazquez Echegaray Awarded a MSCA Postdoctoral Fellowship

Pereira Lab researcher Camila Vazquez Echegaray was awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship.

Eurostars-funded REPRINT Project Kick-off Meeting

The Pereira Lab took part in a meeting held by Asgard Therapeutics AB, together with consortium members InSphero and Antineo, that sets the official kick-off to the earlier announced Eurostars project.

Encoding Human Dendritic Cell Fate

PU.1, IRF8, and BATF3 cooperation and role in inflammatory signaling during programming of human cDC1-like cells was uncovered at the Pereira Lab.

Spin-off From Pereira Lab Raises 6M Euros to Advance In vivo DC Reprogramming

Asgard Therapeutics AB, a private biotech company spin off from the Pereira Lab, announces the completion of a EUR 6 million seed financing round. The financing was co-led by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.

Fábio Rosa Defended His PhD Thesis

On June 10th 2021, Fábio Rosa defended his thesis “Generating Dendritic Cells by Direct Cell Reprogramming. Merging cellular reprogramming with immunology towards the development of novel cancer immunotherapies.” with Prof. Thomas Graf from the Center for Genomic Regulation (Spain) as opponent.

Filipe Pereira Is The New Editor-in-Chief of Cellular Reprogramming

Following on the legacy of Professor Sir Ian Wilmut, Filipe Pereira becomes the new Editor-in-Chief of the Cellular Reprogramming Journal.

Filipe Pereira Awarded a Swedish Research Council Consolidator Grant

The Swedish Research Council (Vetenskapsrådet) has published the results for this year’s applications for consolidator grants, in which Filipe Pereira was selected for, in the scientific area of Medicine and health.

Luís Oliveira Awarded a PhD Studentship From The Foundation for Science and Technology

Pereira Lab researcher Luís Oliveira was awarded a fully funded 4 year scholarship by the Portuguese Foundation for Science and Technology (FCT) to develop his PhD-leading research.

Pereira Lab Funded by the Mats Paulsson Foundation

The Pereira Lab has been awarded a grant from the Mats Paulsson Foundation for Research, Innovation and Societal Development on a project aiming at Harnessing Dendritic Cell Reprogramming for Cancer Immunotherapy.

Filipe Pereira Awarded the KiiLNYC Postdoc Entrepreneurship Award

Filipe Pereira was recently awarded with the KiiLN Postdoctoral Entrepreneurship Award by the Keystone for Incubating Innovation in Life Sciences Network at the Icahn School of Medicine Innovation Awards.

Olga Zimmermannova Awarded a Grant From the Royal Physiographic Society of Lund

Pereira Lab Cancerfonden postdoctoral fellow Olga Zimmermannova was awarded a grant from the Royal Physiographic Society of Lund, one of the Royal Academies promoting scientific progress in Sweden.

Pereira Lab Awarded Funding From the Swedish Cancer Society and the Portuguese Foundation for Science and Technology

The project entitled “Understanding dendritic cell diversity with cell reprogramming” aims at a better comprehension of dendritic cell development, with interesting new possibilities in cancer immunotherapy.

Prestigious ERC consolidator grant for innovative immunotherapy research at the Pereira Lab

Filipe Pereira was today announced as one of the 89 selected researchers by the European Research Council of its latest Consolidator Grant competition. He will be awarded an ERC Consolidator Grant of 2 million EUR over a period of five years. The project will merge the cell reprogramming and cancer immunotherapy fields to develop innovative therapeutic strategies.